QualityStocks would like to highlight STAAR Surgical Company (NASDAQ: STAA). STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye. All of these lenses are foldable, which permits the surgeon to insert them through a small incision.
In the company’s news yesterday,
STAAR Surgical Company detailed its activities scheduled before and during the 2011 Congress of European Society of Cataract and Refractive Surgeons (ESCRS) this weekend, during which the company will officially launch two key products in Europe and other countries that accept CE Mark approvals.
The Congress will be held in Vienna, Austria, September 17 through 21, 2011. STAAR will launch its Visian Implantable Collamer® Lens (ICL) with CentraFLOW™ technology, which utilizes the KS-AquaPORT™, and the nanoFLEX™ IOL, both of which the company received CE Mark approval for in April 2011.
Beginning today, STAAR will hold its 8th Annual Visian ICL Experts Symposium. The company said it anticipates more than 100 surgeons from 34 countries to attend the “by invitation only” roundtable discussion sessions on the Visian ICL technology.
Hans Blickensdoerfer, president of Europe and Latin America for STAAR, said the meeting not only represents the official unveiling of its key products, but is also a celebration of a recent significant achievement.
“We anticipate this will be the most exciting and productive ESCRS meeting in our history,” Blickensdoerfer stated in the press release. “We will be celebrating the key milestone of over a quarter of a million successful Visian ICL implants at the same time we are introducing the new Visian ICL with CentraFLOW technology.”
Blickensdoerfer said that over its 15-year history with Visian ICL, it has become the fastest growing refractive technology in the world.
“Now, for the first time in our history, the Visian ICL can treat all LASIK eligible patients and more, while the procedure is as convenient for both the patient and surgeon, if not more so, than LASIK. In other words, we are now on at least an equal playing level with LASIK and we believe with even better visual results for the patient,” he stated.
The ESCRS Congress official program begins Saturday and will include more than 50 presentations in which the Visian ICL technology will be presented.
On Monday, STAAR will host the ESCRS Lunch Symposium entitled, “Revolutions in Refractive Surgery,” which is expected to draw up to 400 surgeons. The luncheon will include six presentations by surgeons from six different countries detailing their experience with the Visian ICL technology, including the new Visian ICL with CentraFLOW technology.
About QualityStocks
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net
Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
